Indinavir

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Virustatic.

Pharmacodynamics (Effect)This section has been translated automatically.

Inhibitor of the HIV-associated protease.

IndicationThis section has been translated automatically.

Combination therapy of HIV infection.

Limited indicationThis section has been translated automatically.

Nephrolithiasis and hyperuricemia in medical history, pregnancy, children.

Dosage and method of useThis section has been translated automatically.

  • 3 times/day 800 mg p.o. as mono-protease inhibitor.
  • Combination therapy with ritonavir: 2 times/day 400 mg indinavir + 2 times/day 100 mg ritonavir p.o.

Undesirable effectsThis section has been translated automatically.

Kidney pain and stones, hyperbilirubinemia > 2.5 mg/l, insomnia, pharyngitis, dry skin, altered taste perception.

Notice! Stop therapy if hyperbilirubinemia > 5 mg/l.

InteractionsThis section has been translated automatically.

When taking ketoconazole, reduce the dose of indinavir to 3 times/day 600 mg p.o.; when taking rifabutin in parallel, reduce rifabutin by half.

PreparationsThis section has been translated automatically.

Crixivan

PatientinformationThis section has been translated automatically.

Remember! High liquid intake (min. 3 litres/day). Take 1 hour before or 2 hours after meals. Exception: light breakfast with cornflakes, milk, sugar, coffee!

LiteratureThis section has been translated automatically.

  1. Eron JJ JR. (2002) HIV-1 protease inhibitors. Clin Infect Dis 30: 160-170

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer